Clinical Trial: Treatment Workflow Study Comparing Intravenous and Subcutaneous Administration of Isatuximab for Multiple Myeloma Treatment: Understanding Impact on Healthcare Resource Utilization from HCPs' Perspective (Japan)

Tokyo, June 28 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058306) titled 'Treatment Workflow Study Comparing Intravenous and Subcutaneous Administration of Isatuximab for Multiple Myeloma Treatment: Understanding Impact on Healthcare Resource Utilization from HCPs' Perspective' on June 27.

Study Type: Observational

Primary Sponsor: Institute - Sanofi K.K.

Condition: Condition - Multiple myeloma Classification by malignancy - Malignancy Genomic information - NO

Objective: Narrative objectives1 - To evaluate the workflow associated with intravenous administration of Isatuximab versus subcutaneous administration of Isatuximab for the treatment of multiple myeloma from a healthcare system ...